Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0423716 (
Neuropathic pain
)
1,417
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neuropathic pain
induced by peripheral nerve injury is a complex and chronic state that is accompanied by poor quality of life. However, whether
PIM1
(proviral integration site 1) contributes to the development of nociceptive hypersensitivity induced by nerve injury remains unknown. The present study was designed to investigate the effects of
PIM1
on spinal nerve ligation (SNL) induced pain hypersensitivity. Here, we found that
PIM1
positive neurons in the dorsal root ganglion (DRG) were colocalized with nociceptive neuronal markers CGRP, IB4 and substance P and were upregulated after SNL surgery. Knockdown
PIM1
in the DRG by AAV5-shPIM1 alleviated SNL-induced pain hypersensitivity. In neuroblastoma cells (neuro-2a),
PIM1
regulated the expression of CXCR4 phosphorylated at ser339 (pCXCR4) as well as the CXCL12/CXCR4 pathway. In the DRG tissues, we found that
PIM1
was co-expressed with CXCR4, and knockdown of
PIM1
attenuated pCXCR4 (ser339) protein expression but had little effect on total CXCR4 protein expression after SNL surgery. These findings suggest that
PIM1
contributes to nerve injury-induced nociceptive hypersensitivity. Based on these findings and the characteristics of
PIM1
, we speculate that
PIM1
might be a viable therapeutic target for the treatment of neuropathic pain in the near future.
...
PMID:The role of dorsal root ganglia PIM1 in peripheral nerve injury-induced neuropathic pain. 3134 16